1. Home
  2. HALO vs AES Comparison

HALO vs AES Comparison

Compare HALO & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • AES
  • Stock Information
  • Founded
  • HALO 1998
  • AES 1981
  • Country
  • HALO United States
  • AES United States
  • Employees
  • HALO N/A
  • AES N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • AES Electric Utilities: Central
  • Sector
  • HALO Health Care
  • AES Utilities
  • Exchange
  • HALO Nasdaq
  • AES Nasdaq
  • Market Cap
  • HALO 7.4B
  • AES 7.1B
  • IPO Year
  • HALO N/A
  • AES 1991
  • Fundamental
  • Price
  • HALO $52.02
  • AES $12.21
  • Analyst Decision
  • HALO Buy
  • AES Buy
  • Analyst Count
  • HALO 9
  • AES 7
  • Target Price
  • HALO $63.56
  • AES $12.86
  • AVG Volume (30 Days)
  • HALO 3.1M
  • AES 15.5M
  • Earning Date
  • HALO 05-06-2025
  • AES 05-01-2025
  • Dividend Yield
  • HALO N/A
  • AES 5.76%
  • EPS Growth
  • HALO 55.40
  • AES 146.43
  • EPS
  • HALO 3.76
  • AES 1.83
  • Revenue
  • HALO $1,084,306,000.00
  • AES $12,119,000,000.00
  • Revenue This Year
  • HALO $24.79
  • AES $4.10
  • Revenue Next Year
  • HALO $22.65
  • AES $2.95
  • P/E Ratio
  • HALO $13.83
  • AES $6.69
  • Revenue Growth
  • HALO 25.64
  • AES N/A
  • 52 Week Low
  • HALO $41.28
  • AES $9.57
  • 52 Week High
  • HALO $70.51
  • AES $22.21
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • AES 65.04
  • Support Level
  • HALO $47.50
  • AES $10.19
  • Resistance Level
  • HALO $69.94
  • AES $12.67
  • Average True Range (ATR)
  • HALO 3.52
  • AES 0.42
  • MACD
  • HALO -1.49
  • AES 0.29
  • Stochastic Oscillator
  • HALO 19.64
  • AES 83.21

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: